Long-term clinical and immunologic consequences of inflammation in perinatal HIV

Active Project Grant Awarded Last action

Award ID
R01HD113487
Recipient
Awarding agency
Obligated
$2,887,518

Award facts

Completion date 48% complete
Place of performance
Indianapolis, IN 46202, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Globally, 2.7 million children are living with HIV and 270,000 new infections occur annually. With antiretroviral therapy (art) that suppresses viremia these children are surviving through adolescence into adulthood, but art may not fully restore immunologic health and inflammation may persist despite early art initiation. In adults living with HIV (ALHIV) inflammation has been associated with higher incidence of cardiovascular, metabolic and neurocognitive age-related comorbidities than persons without HIV. Because immunologic and neurologic development occur alongside exposure to HIV and art in children with perinatal HIV (CPHIV), the long-term consequences of inflammation may differ from adults and is largely unknown. In a cross-sectional study of kenyan CPHIV, we previously reported that inflammation persists despite viral suppression on art. The proposed research leverages this cohort in a 10-year follow up study to determine whether viral suppression on prolonged art dampens immune activation, the pathogenic mediators of inflammation and the consequences of sustained inflammation with a global assessment of immunologic, cardiovascular, metabolic and neurocognitive outcomes. The follow up cohort will include 80 persons with perinatal HIV (PPHIV) on art for ~11 years and 82 persons unexposed to HIV (HU). In aim 1, the durability of inflammation and immune dysregulation in PPHIV on long-term art with viral suppression will be assessed by comparing monocyte (SCD14, SCD163), T cell (CD38, HLA-DR) and plasma (hscrp, TNF-Α, IL-6) inflammatory markers and innate and adaptive immune cell subsets between baseline (T0, 2012 PIA study) and 10-year follow-up (T1) levels. The pathogenic role of viral reservoir size and replicative capacity and intestinal permeability on immune activation will also be assessed. In aim 2 we will examine whether early (T0) or concurrent (T1) inflammatory markers correlate with clinical outcomes including 1) cardiovascular measures of myocardial function by echocardiogram and endothelial dysfunction by endothelial peripheral arterial tonometry (ENDOPAT), 2) metabolic measures of insulin resistance by homa-IR and pancreatic beta cell function and stress by homa-B and proinsulin/C-peptide ratios and 3) neurocognitive assessments using neuroscreen, a tablet-based tool that evaluates six neuropsychological domains most affected by HIV. The proposed study will be among the first to comprehensively examine multisystemic immunologic, cardiovascular, metabolic and neurocognitive outcomes in PPHIV in sub-saharan africa after prolonged viral suppression. Our research will fill fundamental knowledge gaps in understanding the role of early childhood inflammation in durable health outcomes of PPHIV, with potential to identify screening biomarkers and implement preventative interventions that mitigate HIV-related comorbidities so PPHIV can thrive as adults.

Transactions

Action Obligated Date
Amendment $63,167
Amendment $663,695
Amendment $663,695
Amendment $75,508
Amendment $75,508
Amendment $75,508
Amendment -$75,508
Amendment -$75,508
Amendment -$75,508
Amendment $75,508
Amendment $665,376
Amendment $0
Amendment $0
Original award $756,077
Show all 14

Subawards

Subrecipient Amount Awarded
Mkomani Clinic Society The work to be covered will include, but not be limited to: provision of necessary study personnel and direct management of subcontracted study funds;… $63,167
Mkomani Clinic Society The work to be covered will include, but not be limited to: provision of necessary study personnel and direct management of subcontracted study funds;… $75,508
Mkomani Clinic Society The work to be covered will include, but not be limited to: provision of necessary study personnel and direct management of subcontracted study funds;… $82,590

Quick answers

Who received award R01HD113487?

R01HD113487 was awarded to Trustees Of Indiana University by National Institute of Child Health and Human Development (National Institutes of Health) on August 7, 2024.

How much is award R01HD113487 worth?

$2,887,518 has been obligated on R01HD113487.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login